Atlas Trials

Generalized Arterial Calcification of Infancy

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Generalized Arterial Calcification of Infancy

RecordFirmDate
The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency (NCT06046820)Inozyme Pharma2023-11-05
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency (NCT05734196)Inozyme Pharma2023-06-25
Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency (NCT05050669)Inozyme Pharma2022-06-28
Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE (NCT05030831)Inozyme Pharma2022-04-11
Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency (NCT04686175)Inozyme Pharma2021-11-21
Natural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency (NCT07745179)Inozyme Pharma2018-12-05
Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2) (NCT03478839)National Human Genome Research Institute (NHGRI)2018-04-17

Track Generalized Arterial Calcification of Infancy automatically

Every clearance here is in the API, with alerts when new ones post.